Search In this Thesis
   Search In this Thesis  
العنوان
Outcome of Intravenous Thrombolytic Therapy in a Sample of Egyptian Patients with Acute Ischemic Stroke: Correlation with Possible Predictors/
الناشر
Ain Shams University.
المؤلف
Khalil ,Mohamed Fouad El-Sayed .
هيئة الاعداد
باحث / محمد فؤاد السيد خليل
مشرف / هاني محمد أمين عارف
مشرف / هالة محمود الخواص
مشرف / محمد أمير ترك
مشرف / أحمد محمد الصادق
تاريخ النشر
2020
عدد الصفحات
211.p;
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
الطب النفسي والصحة العقلية
تاريخ الإجازة
1/4/2020
مكان الإجازة
جامعة عين شمس - كلية الطب - Neurology
الفهرس
Only 14 pages are availabe for public view

from 205

from 205

Abstract

Stroke is a complex disease and one of the main causes of morbidity and mortality among the adult population. Risk factors for stroke are well established and include familial and genetic factors, gender and ethinicity, high blood pressure, DM, AF, high cholesterol, smoking, alcohol, stress, physical inactivity and obesity, chronic kidney disease, hematological disorders, arterial diseases, infections, vasculitis, drug induced and interactions between these factors. IV rtPA has become the standard therapy for patients presenting within 3 hours of onset of acute ischemic stroke and then that time window has been extended to 4.5 hours with additional exclusions. Despite the recent advances in the field center around interventional stroke neurology and direct intra-arterial therapies, treatment of patients with endovascular therapy has not proved to be superior in improving patient outcomes compared with IV rtPA. A huge variety of factors are known to influence patient outcome, including demographic variables, genetics, stroke severity, onset to treatment time, stroke etiological mechanism, stroke lesion location, comorbid conditions, PI, related complications, stroke unit care, and rehabilitation. All these factors influence the functional outcome among ischemic stroke patients after receiving IV rtPA. Knowledge of these prognostic factors enables the clinician to make a reasonable prediction for each patient, to offer a rational treatment to the patients, and to help the family members understand the disease course aiming for more reduction of morbidities and mortalities among stroke patients and provide them with better post-stroke quality of life.